Overview
Clinical Drug Investigation covers:
- Clinical trials
- Outcomes research
- Pharmacoeconomics studies
- Pharmacoepidemiology studies
- Pharmacodynamic and pharmacokinetic studies
- Application of drug-delivery technology in healthcare
As a hybrid journal, Clinical Drug Investigation does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).
Clinical Drug Investigation offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).
- Editor
-
- Jasbir Singh
- Impact factor
- 3.2 (2022)
- 5 year impact factor
- 2.5 (2022)
- Submission to first decision (median)
- 5 days
- Downloads
- 411,717 (2023)
Latest articles
Journal updates
-
Digital Features
Clinical Drug Investigation is able to host a range of digital features, with a number of options available to authors.
Journal information
- Electronic ISSN
- 1179-1918
- Print ISSN
- 1173-2563
- Abstracted and indexed in
-
- ANVUR
- BFI List
- BIOSIS
- Baidu
- Biological Abstracts
- CAB Abstracts
- CLOCKSS
- CNKI
- CNPIEC
- Chemical Abstracts Service (CAS)
- Current Contents/Clinical Medicine
- Current Contents/Life Sciences
- Dimensions
- EBSCO
- EMBASE
- Google Scholar
- Japanese Science and Technology Agency (JST)
- Medline
- Naver
- OCLC WorldCat Discovery Service
- Portico
- ProQuest
- Reaxys
- SCImago
- SCOPUS
- Science Citation Index Expanded (SCIE)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)
- Wanfang
- Copyright information